{"name": "Horizon Pharma",
 "permalink": "horizon-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/horizon-therapeutics",
 "homepage_url": "http://www.horizonpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "jwhalen@horizonpharma.com",
 "phone_number": "224-383-3000",
 "description": "biopharmaceutical company",
 "created_at": "Tue Dec 15 21:40:04 UTC 2009",
 "updated_at": "Fri Jul 29 04:06:12 UTC 2011",
 "overview": "\u003Cp\u003EHorizon Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company\u0026#8217;s product candidates include HZT-501, a proprietary fixed dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. \u003C/p\u003E\n\n\u003Cp\u003EHorizon Therapeutics, Inc. was founded in 2005 and is headquartered in Northbrook, Illinois with an additional office in Palo Alto, California. As of April 1, 2010, Horizon Therapeutics, Inc. operates as a subsidary of Horizon Pharma, Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       56],
      "assets/images/resized/0008/7191/87191v1-max-150x150.jpg"],
     [[250,
       94],
      "assets/images/resized/0008/7191/87191v1-max-250x250.jpg"],
     [[254,
       96],
      "assets/images/resized/0008/7191/87191v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Louis",
      "last_name": "Bock",
      "permalink": "louis-bock",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0006/9978/69978v1-max-150x150.jpg"],
          [[168,
            250],
           "assets/images/resized/0006/9978/69978v1-max-250x250.jpg"],
          [[179,
            266],
           "assets/images/resized/0006/9978/69978v1-max-450x450.jpg"]],
        "attribution": "\u003Cp\u003EScale VP\u003C/p\u003E"}}},
   {"is_past": true,
    "title": "Board Observer",
    "person":
     {"first_name": "Patrick",
      "last_name": "Enright",
      "permalink": "patrick-enright",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$51.1M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://liquidscenarios.com/s2m/?c=Horizon Therapeutics",
    "source_description": "SEC Filing Via Liquid Scenarios Search2Model",
    "raised_amount": 6050000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 10,
    "funded_day": null,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://liquidscenarios.com/s2m/?c=Horizon+Therapeutics",
    "source_description": "SEC Filing Via Liquid Scenarios Search2Model",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": null,
    "investments":
     []},
   {"round_code": "c",
    "source_url": "http://liquidscenarios.com/s2m/?c=Horizon+Therapeutics",
    "source_description": "SEC Filing Via Liquid Scenarios Search2Model",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 7,
    "funded_day": null,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "1033 Skokie Boulevard",
    "address2": "Suite 355",
    "zip_code": "60062",
    "city": "Northbrook",
    "state_code": "IL",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Horizon Pharma Takes $35M Bridge Loan To Reach IPO Day  ",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 23,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110122e71o00001\u0026r=Rss\u0026s=DJFVW",
    "source_text": "",
    "source_description": "Horizon Pharma Takes $35M Bridge Loan To Reach IPO Day  ",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Horizon Pharma",
      "permalink": "horizon-therapeutics"}},
   {"description": "Horizon Pharma Announces Pricing of its Initial Public Offering",
    "stoned_year": 2011,
    "stoned_month": 7,
    "stoned_day": 28,
    "source_url": "http://www.horizonpharma.com/ArticleDetail.asp?tid=167",
    "source_text": "",
    "source_description": "Horizon Pharma Announces Pricing of its Initial Public Offering",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Horizon Pharma",
      "permalink": "horizon-therapeutics"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": 2011,
   "pub_month": 7,
   "pub_day": 28,
   "stock_symbol": "NASDAQ:HZNP"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        122],
       "assets/images/resized/0008/7192/87192v1-max-150x150.jpg"],
      [[250,
        203],
       "assets/images/resized/0008/7192/87192v1-max-250x250.jpg"],
      [[450,
        366],
       "assets/images/resized/0008/7192/87192v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}